ClinicalTrials.gg
Drug

Dehydroepiandrosterone clinical trials

Also written DHEA and Intrarosa.

Includes 2 studies of Dehydroepiandrosterone Sulfate.

studies test it
94
open now
11
in phase 3
43
first study started
1994

How each study uses Dehydroepiandrosterone is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Dehydroepiandrosterone studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
16 Nov 2016 · INTRAROSA · NDA 208470 (FDA, Drugs@FDA)
European Union
8 Jan 2018 · Intrarosa · EMEA/H/C/004138 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Dehydroepiandrosterone
33
Dehydroepiandrosterone (DHEA)
7
Prasterone (DHEA)
4
Prasterone, Dehydroepiandrosterone
3
DHEA tablet
2

Brand

Intrarosa
7

Development codes

GL701
1

Other names

DHEA
37
Prasterone
6
Dehydroisoandrosterone
1
Prasterone 6.5 MG
1

Studies by the year they started

93 studies that test it; most in 2010 (7); 1 more planned to start later

Studies that test Dehydroepiandrosterone, by start year
YearStudies
19941
19953
19961
19971
19981
20003
20013
20022
20034
20042
20053
20064
20074
20082
20092
20107
20113
20122
20133
20146
20154
20163
20174
20184
20192
20204
20213
20225
20231
20241
20252
20263

By phase

A phase 1/2 study counts in both.

Early Phase 1
4
Phase 1
7
Phase 2
27
Phase 3
43
Phase 4
8
No phase
17

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 17 · Other 77

EndoCeutics Inc. (9) · Cairo University (4) · National Center for Research Resources (NCRR) (4) · CHU de Quebec-Universite Laval (3) · Genelabs Technologies (3) · University of Maryland, Baltimore (2) · Kaohsiung Veterans General Hospital. (2) · ShangHai Ji Ai Genetics & IVF Institute (2)

Often tested with

Tested in the same studies.

Testosterone (3) · Pregnenolone (2) · Fluoxetine (1) · Estrogens (1) · Estradiol (1) · Coenzyme Q10 (1) · Tocotrienols (1) · BAY86-5314 (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 3, 1 in phase 3

Studies that test Dehydroepiandrosterone, phase 3 first.

Studies

Open first, then newest update. How each study uses Dehydroepiandrosterone is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 94

See all 94 studies that test Dehydroepiandrosterone →

Given beside what is tested · 3 — Dehydroepiandrosterone is usual care or a partner of the new treatment
As the comparator · 2 — what is tested is compared with Dehydroepiandrosterone

Codes

What other systems call Dehydroepiandrosterone · ClinicalTrials.gg INT007306

  • MeSH (NLM) D003687DehydroepiandrosteroneConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 459AG36T1BPRASTERONEConfirmed FDA, NLM, Wikidata
  • RxNorm 3143Confirmed FDA, Wikidata
  • Wikidata Q408376dehydroepiandrosteroneConfirmed FDA, NLM, Wikidata
  • DrugBank DB01708One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.